ACADIA Pharmaceuticals Ownership & Insider Activity

ACADIA Pharmaceuticals (ACAD) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.7% of shares outstanding. Institutional investors hold 45.7%.

Shares Outstanding

171.215M

Shares Float

107.941M

Insider Shares Owned

1.236M

Insider % Owned

0.7%

Institutional Shares Held

78.757M

Institutional % Held

45.7%

Ownership Breakdown

Net Insider Activity by Month

ACADIA Pharmaceuticals Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Aug 5, 2026	Mark Schneyer	EVP, CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$23.50	$228K
Jul 29, 2026	HZ Elizabeth Thompson	EVP, HEAD RESEARCH & DEV	SELL-OPTIONS	15.714K	$26.13	$433K
Jun 26, 2026	James Kihara	PRINCIPAL ACCOUNTING OFFICER	SELL	11.421K	$26.08	$298K
May 26, 2026	James Kihara	PRINCIPAL ACCOUNTING OFFICER	SELL	5.401K	$21.18	$114K
May 1, 2026	James Kihara	PRINCIPAL ACCOUNTING OFFICER	SELL-OPTIONS	1.264K	$21.79	$29K
May 1, 2026	Mark Schneyer	EVP, CHIEF FINANCIAL OFFICER	SELL-OPTIONS	3.309K	$21.79	$76K
Apr 5, 2026	Mark Schneyer	EVP, CHIEF FINANCIAL OFFICER	SELL-OPTIONS	2.567K	$22.20	$60K
Apr 5, 2026	James Kihara	PRINCIPAL ACCOUNTING OFFICER	SELL-OPTIONS	980.000	$22.20	$23K

Date	Member	Party	Chamber	Action	Amount
Jun 16, 2022	Chris Jacobs	R	House	Sale	$1,001 - $15,000